187 related articles for article (PubMed ID: 15134533)
1. The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directions.
Rooney PH; Telfer C; McFadyen MC; Melvin WT; Murray GI
Curr Cancer Drug Targets; 2004 May; 4(3):257-65. PubMed ID: 15134533
[TBL] [Abstract][Full Text] [Related]
2. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs].
Quiñones S L; Rosero P M; Roco A A; Moreno T I; Sasso A J; Varela F N; Cáceres L D; Saavedra S I
Rev Med Chil; 2008 Oct; 136(10):1327-35. PubMed ID: 19194632
[TBL] [Abstract][Full Text] [Related]
3. Cytochromes P450 in the bioactivation of chemicals.
Ioannides C; Lewis DF
Curr Top Med Chem; 2004; 4(16):1767-88. PubMed ID: 15579107
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome p450 and chemical toxicology.
Guengerich FP
Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394
[TBL] [Abstract][Full Text] [Related]
5. Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.
Rendic SP; Guengerich FP
Arch Toxicol; 2021 Feb; 95(2):395-472. PubMed ID: 33459808
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim: novel reactive intermediates and bioactivation pathways by cytochrome p450s.
Damsten MC; de Vlieger JS; Niessen WM; Irth H; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2008 Nov; 21(11):2181-7. PubMed ID: 18816075
[TBL] [Abstract][Full Text] [Related]
7. Roles of different cytochrome P450 enzymes in bioactivation of the potent hepatocarcinogen 3-methoxy-4-aminoazobenzene by rat and human liver microsomes.
Yamazaki H; Degawa M; Funae Y; Imaoka S; Inui Y; Guengerich FP; Shimada T
Carcinogenesis; 1991 Jan; 12(1):133-9. PubMed ID: 1988174
[TBL] [Abstract][Full Text] [Related]
8. Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.
Patterson LH; McKeown SR; Robson T; Gallagher R; Raleigh SM; Orr S
Anticancer Drug Des; 1999 Dec; 14(6):473-86. PubMed ID: 10834269
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cytochrome P450 activity: implications for cancer therapy.
Scripture CD; Sparreboom A; Figg WD
Lancet Oncol; 2005 Oct; 6(10):780-9. PubMed ID: 16198984
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation of the anthraquinones emodin and chrysophanol by cytochrome P450 enzymes. Bioactivation to genotoxic metabolites.
Mueller SO; Stopper H; Dekant W
Drug Metab Dispos; 1998 Jun; 26(6):540-6. PubMed ID: 9616189
[TBL] [Abstract][Full Text] [Related]
11. Human cytochrome p450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1'-hydroxymethyleugenol.
Jeurissen SM; Bogaards JJ; Boersma MG; ter Horst JP; Awad HM; Fiamegos YC; van Beek TA; Alink GM; Sudhölter EJ; Cnubben NH; Rietjens IM
Chem Res Toxicol; 2006 Jan; 19(1):111-6. PubMed ID: 16411663
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene.
Chen L; Waxman DJ; Chen D; Kufe DW
Cancer Res; 1996 Mar; 56(6):1331-40. PubMed ID: 8640822
[TBL] [Abstract][Full Text] [Related]
13. P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues.
Scarborough PE; Ma J; Qu W; Zeldin DC
Drug Metab Rev; 1999 Feb; 31(1):205-34. PubMed ID: 10065373
[TBL] [Abstract][Full Text] [Related]
14. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
Roy P; Waxman DJ
Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390
[TBL] [Abstract][Full Text] [Related]
15. Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/cytochrome P-450 reductase-based cancer gene therapy.
Jounaidi Y; Waxman DJ
Cancer Res; 2001 Jun; 61(11):4437-44. PubMed ID: 11389073
[TBL] [Abstract][Full Text] [Related]
16. Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
McCarthy HO; Yakkundi A; McErlane V; Hughes CM; Keilty G; Murray M; Patterson LH; Hirst DG; McKeown SR; Robson T
Cancer Gene Ther; 2003 Jan; 10(1):40-8. PubMed ID: 12489027
[TBL] [Abstract][Full Text] [Related]
17. Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy.
Jounaidi Y; Hecht JE; Waxman DJ
Cancer Res; 1998 Oct; 58(19):4391-401. PubMed ID: 9766669
[TBL] [Abstract][Full Text] [Related]
18. P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease.
Murray M
Clin Pharmacokinet; 1992 Aug; 23(2):132-46. PubMed ID: 1511529
[TBL] [Abstract][Full Text] [Related]
19. Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.
Pirmohamed M; Madden S; Park BK
Clin Pharmacokinet; 1996 Sep; 31(3):215-30. PubMed ID: 8877251
[TBL] [Abstract][Full Text] [Related]
20. Bioactivation of halogenated hydrocarbons by cytochrome P4502E1.
Raucy JL; Kraner JC; Lasker JM
Crit Rev Toxicol; 1993; 23(1):1-20. PubMed ID: 8471158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
